| GC16299-10mg |
|
1380087-89-7 |
BET bromodomain inhibitor
|
0 |
C20H16ClN3O2 |
|
|
|
| GC16298-25mg |
|
1621862-70-1 |
|
0 |
C27H33F3N4O3 |
|
|
|
| GC16298-5mg |
|
1621862-70-1 |
|
0 |
C27H33F3N4O3 |
|
|
|
| GC16298-2mg |
|
1621862-70-1 |
|
0 |
C27H33F3N4O3 |
|
|
|
| GC16297-10mM (in 1mL DMSO) |
|
144143-96-4 |
|
0 |
C24H28N2O7S2 |
|
|
|
| GC16297-50mg |
|
144143-96-4 |
|
0 |
C24H28N2O7S2 |
|
|
|
| GC16296-100mg |
|
1303607-07-9 |
|
0 |
C29H34Cl2FN3O3 |
|
|
|
| GC16296-50mg |
|
1303607-07-9 |
|
0 |
C29H34Cl2FN3O3 |
|
|
|
| GC16296-10mg |
|
1303607-07-9 |
|
0 |
C29H34Cl2FN3O3 |
|
|
|
| GC16296-5mg |
|
1303607-07-9 |
|
0 |
C29H34Cl2FN3O3 |
|
|
|
| GC16295-10mM (in 1mL DMSO) |
|
5 |
|
0 |
C11H10N4O4 |
|
|
|
| GC16295-100mg |
|
5 |
|
0 |
C11H10N4O4 |
|
|
|
| GC16294-10mM (in 1mL DMSO) |
|
57469-77-9 |
|
0 |
C19H32N2O4 |
|
|
|
| GC16294-20mg |
|
57469-77-9 |
|
0 |
C19H32N2O4 |
|
|
|
| GC16294-100mg |
|
57469-77-9 |
|
0 |
C19H32N2O4 |
|
|
|
| GC16293-100mg |
|
211914-51-1 |
BIBR 953 (Dabigatran, Pradaxa)
|
0 |
C25H25N7O3 |
|
|
|
| GC16293-50mg |
|
211914-51-1 |
BIBR 953 (Dabigatran, Pradaxa)
|
0 |
C25H25N7O3 |
|
|
|
| GC16293-10mg |
|
211914-51-1 |
BIBR 953 (Dabigatran, Pradaxa)
|
0 |
C25H25N7O3 |
|
|
|
| GC16293-5mg |
|
211914-51-1 |
BIBR 953 (Dabigatran, Pradaxa)
|
0 |
C25H25N7O3 |
|
|
|
| GC16292-10mM (in 1mL DMSO) |
|
531-95-3 |
|
0 |
C15H14O3 |
|
|
|
